Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations

  1. Gidding, Samuel S 3
  2. Wiegman, Albert 10
  3. Groselj, Urh 6
  4. Freiberger, Tomas 45
  5. Peretti, Noel 1112
  6. Dharmayat, Kanika I 17
  7. Daccord, Magdalena 3
  8. Bedlington, Nicola 3
  9. Sikonja, Jaka 6
  10. Ray, Kausik K 17
  11. Santos, Raul D 789
  12. Halle, Martin 1516
  13. Tokgözoğlu, Lale 14
  14. Gutiérrez-Ibarluzea, Iñaki 13
  15. Pinto, Fausto J 12
  16. Geanta, Marius 3
  1. 1 World Heart Federation , Geneva , Switzerland
  2. 2 Cardiovascular Department, CCUL, CAML, Lisbon School of Medicine, University of Lisbon , Portugal
  3. 3 The European FH Patient Network (FH Europe), Star House, Star Hill , Rochester, Kent ME1 1UX , UK
  4. 4 Centre for Cardiovascular Surgery and Transplantation , Pekařská 53, 656 91 Brno , Czech Republic
  5. 5 Medical Faculty, Masaryk University , Kamenice 5, 625 00 Brno , Czech Republic
  6. 6 Department of Endocrinology, Diabetes, and Metabolic Diseases, University Children’s Hospital, University Medical Centre Ljubljana , Bohoričeva ulica 20, Ljubljana , Slovenia
  7. 7 Heart Institute (InCor), University of Sao Paulo Medical School Hospital , Sao Paulo , Brazil
  8. 8 Preventive Medicine Centre and Cardiology Program, Hospital Israelita Albert Einstein , Sao Paulo , Brazil
  9. 9 International Atherosclerosis Society (IAS) , Milan , Italy
  10. 10 Department of Paediatrics, Amsterdam University Medical Centers, University of Amsterdam , Meibergdreef 9, 1105 AZ Amsterdam , The Netherlands
  11. 11 Department of Pediatric Gastroenterology-Hepatology and Nutrition, Hospices Civil de Lyon HCL, Hôpital Femme Mere Enfant HFME, Bron , France
  12. 12 Univ-Lyon, CarMeN Laboratory, INSERM U1060, INRAE U1397, Université Claude Bernard Lyon-1 , Oullins, Lyon , France
  13. 13 Head of Knowledge Management and Health Technology Assessment, Basque Foundation for Health Innovation and Research (BIOEF) , Ronda de Azkue, 1, 48902 Barakaldo (Bizkaia), Basque Country , Spain
  14. 14 Department of Cardiology, Hacettepe University, Ankara , Turkey
  15. 15 Department of Prevention and Sports Medicine, Faculty of Medicine, University Hospital ‘Klinikum rechts der Isar’, Technical University Munich , Munich , Germany
  16. 16 DZHK (Deutsches Zentrum für Herz-Kreislauf-Forschung), partner site Munich, Munich Heart Alliance , Munich , Germany
  17. 17 Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College London , St Dunstan’s Road, London W6 8RP , UK
Mostrar afiliaciones +
Revista:
European Journal of Preventive Cardiology

ISSN: 2047-4873,  2047-4881

Año de publicación: 2022

Tipo: Artículo

DOI: 10.1093/EURJPC/ZWAC200 WoS: MEDLINE:36059237 GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: European Journal of Preventive Cardiology

Objetivos de desarrollo sostenible

€ Ver financiación

Información de financiación

Financiadores

  • European Familial Hypercholesterolaemia Patient Network

Referencias bibliográficas

  • Wiegman, (2015), Eur Heart J, 36, pp. 2425, 10.1093/eurheartj/ehv157
  • Khera, (2016), J Am Coll Cardiol, 67, pp. 2578, 10.1016/j.jacc.2016.03.520
  • Myers, (2021), Am J Prev Cardiol, 7, pp. 100197, 10.1016/j.ajpc.2021.100197
  • Representatives of the Global Familial Hypercholesterolemia Community, (2020), JAMA Cardiol, 5, pp. 217, 10.1001/jamacardio.2019.5173
  • Hu, (2020), Circulation, 141, pp. 1742, 10.1161/CIRCULATIONAHA.119.044795
  • Beheshti, (2020), J Am Coll Cardiol, 75, pp. 2553, 10.1016/j.jacc.2020.03.057
  • Luirink, (2019), N Engl J Med, 381, pp. 1547, 10.1056/NEJMoa1816454
  • Vallejo-Vaz, (2018), Atherosclerosis, 277, pp. 234, 10.1016/j.atherosclerosis.2018.08.051
  • Vallejo-Vaz, (2021), Lancet, 398, pp. 1713, 10.1016/S0140-6736(21)01122-3
  • Ference, (2017), Eur Heart J, 38, pp. 2459, 10.1093/eurheartj/ehx144
  • Robinson, (2018), J Am Heart Assoc, 7, pp. e009778, 10.1161/JAHA.118.009778
  • Versmissen, (2008), BMJ, 337, pp. a2423, 10.1136/bmj.a2423
  • Talasaz, (2021), Pharmacotherapy, 41, pp. 1009, 10.1002/phar.2635
  • Kreissl, (2019), BMC Pediatr, 19, pp. 208, 10.1186/s12887-019-1586-4
  • Vrablík, (2017), Physiol Res, 66, pp. S1, 10.33549/physiolres.933600
  • Kordonouri, (2019), Atherosclerosis, 280, pp. 85, 10.1016/j.atherosclerosis.2018.11.011
  • Sanin, (2022), Eur J Public Health, 32, pp. 422, 10.1093/eurpub/ckac007
  • O’Kane, (2012), Adv Ther, 29, pp. 456, 10.1007/s12325-012-0021-0
  • Averna, (2017), Atheroscler Suppl, 29, pp. 11, 10.1016/j.atherosclerosissup.2017.07.001
  • Latkovskis, (2018), Atherosclerosis, 277, pp. 347, 10.1016/j.atherosclerosis.2018.06.011
  • Petrulioniene, (2018), Atherosclerosis, 277, pp. 407, 10.1016/j.atherosclerosis.2018.06.012
  • Zuurbier, (2021), Genes (Basel), 12, pp. 1168, 10.3390/genes12081168
  • Besseling, (2015), Atherosclerosis, 241, pp. 597, 10.1016/j.atherosclerosis.2015.06.011
  • Mundal, (2016), Eur J Prev Cardiol, 23, pp. 1962, 10.1177/2047487316666371
  • Bourbon, (2008), Atherosclerosis, 196, pp. 633, 10.1016/j.atherosclerosis.2007.07.019
  • Groselj, (2018), Atherosclerosis, 277, pp. 383, 10.1016/j.atherosclerosis.2018.06.858
  • Sustar, (2022), Genet Med, 10.1016/j.gim.2022.06.010
  • Klančar, (2015), J Am Coll Cardiol, 66, pp. 1250, 10.1016/j.jacc.2015.07.017
  • Miserez, (2018), Atherosclerosis, 277, pp. 282, 10.1016/j.atherosclerosis.2018.08.009
  • Kerr, (2017), Eur Heart J, 38, pp. 1832, 10.1093/eurheartj/ehx111
  • Sjouke, (2015), Eur Heart J, 36, pp. 560, 10.1093/eurheartj/ehu058
  • Sustar, (2022), Front Genet, 13, pp. 936121, 10.3389/fgene.2022.936121
  • Williams, (1993), Am J Cardiol, 72, pp. 18D, 10.1016/0002-9149(93)90006-X
  • WHO Human Genetics Programme, (1997), Familial Hypercholesterolemia (FH): Report of a WHO Consultation
  • Groselj, (2022), Eur Heart J, pp. ehac224
  • Morris, (2012), Am J Med Genet A, 158A, pp. 78, 10.1002/ajmg.a.34368
  • Mach, (2020), Eur Heart J, 41, pp. 111, 10.1093/eurheartj/ehz455
  • Vuorio, (2019), Cochrane Database Syst Rev, 2019, pp. CD006401
  • Ramaswami, (2020), Atherosclerosis, 292, pp. 178, 10.1016/j.atherosclerosis.2019.11.012
  • Bogsrud, (2018), J Clin Lipidol, 12, pp. 375, 10.1016/j.jacl.2017.11.009
  • Ademi, (2014), J Clin Lipidol, 8, pp. 390, 10.1016/j.jacl.2014.05.008
  • Pelczarska, (2018), Atherosclerosis, 270, pp. 132, 10.1016/j.atherosclerosis.2018.01.036
  • Oliva, (2009), Rev Esp Cardiol, 62, pp. 57, 10.1016/S0300-8932(09)70021-1
  • Ademi, (2020), Atherosclerosis, 304, pp. 1, 10.1016/j.atherosclerosis.2020.05.007
  • McKay, (2018), Atherosclerosis, 275, pp. 434, 10.1016/j.atherosclerosis.2018.05.047
  • Schwiter, (2020), J Genet Couns, 29, pp. 1142, 10.1002/jgc4.1266
  • Wand, (2020), J Genet Couns, 29, pp. 919, 10.1002/jgc4.1194
  • Jones, (2020), Res Social Adm Pharm, 16, pp. 390, 10.1016/j.sapharm.2019.06.006
  • US Preventive Services Task Force, (2016), JAMA, 316, pp. 625, 10.1001/jama.2016.9852
  • Gidding, (2016), JAMA Cardiol, 1, pp. 859, 10.1001/jamacardio.2016.2871